...
首页> 外文期刊>Radiology >Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology.
【24h】

Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology.

机译:低渗制剂的使用和预防性用药,以减少对射线照相造影剂产生不良反应的频率:泌尿外科学会的一项调查。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess the decisions made by uroradiologists regarding choice of type of intravenous contrast material (low-osmolar contrast media [LOCM] vs conventional ionic agents) and frequency of use of corticosteroid prophylaxis. MATERIALS AND METHODS: A questionnaire was mailed to 158 members of the Society of Uroradiology. There were 108 responses received, yielding a response rate of 68%. Results from 76 represented institutions were tabulated. RESULTS: Most respondents practice at institutions in which LOCM are used selectively rather than universally. Corticosteroid prophylaxis in patients at risk is used with similar frequency at both types of institutions. There is considerable diversity in pretreatment regimens (ie, type and dose of corticosteroid used). Although antihistamines are used by many uroradiologists (almost always in conjunction with corticosteroids), H2 receptor antagonists are used at only a few institutions. CONCLUSION: At institutions in which LOCM are used selectively, the majority of respondents use LOCM quite liberally, with most choosing these agents in patients at risk. Corticosteroid prophylaxis is widely used by respondents. There is much variation in the type of pretreatment regimen and its use in specific clinical settings.
机译:目的:评估泌尿放射科医生在选择静脉造影剂类型(低渗透压造影剂[LOCM]与常规离子剂)以及使用皮质类固醇预防剂的频率方面的决定。材料与方法:将问卷调查表邮寄给泌尿外科学会的158名成员。收到108份回应,回应率为68%。将来自76个代表机构的结果制成表格。结果:大多数受访者在有选择地而不是普遍使用LOCM的机构进行实践。在两种类型的机构中,有风险的患者对皮质类固醇的预防使用频率相似。预处理方案(即所用皮质类固醇的类型和剂量)存在很大差异。尽管许多泌尿放射科医生使用抗组胺药(几乎总是与皮质类固醇联用),但只有少数机构使用H2受体拮抗剂。结论:在选择性使用LOCM的机构中,大多数受访者相当宽松地使用LOCM,大多数在有风险的患者中选择这些药物。受访者广泛使用皮质类固醇预防。预处理方案的类型及其在特定临床环境中的使用存在很大差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号